Chromadex share price today

(CDXC)

Chromadex share price is $5.49 & ₹466.52 as on 21 Dec 2024, 2.30 'hrs' IST

$5.49

▲

0.08

(1.48%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Chromadex share price in Dollar and Rupees. Guide to invest in Chromadex from India. Also see the sentimental analysis on Indian investors investing in Chromadex. Get details on the Indian mutual funds that are investing in Chromadex. Get Analyst recommendations and forecasts along with all the Chromadex's financials.

Chromadex share price movements

Today's Low: $5.26
Today's High: $5.55
$5.49
4.19%
Downside
Day's Volatility :5.23%
Upside
1.08%
52 Weeks Low: $1.36
52 Weeks High: $7.97
$5.49
75.23%
Downside
52 Weeks Volatility :82.94%
Upside
31.15%

Chromadex Returns

Period	Chromadex Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	46.79%	-11.1%	0.0%
6 Months	115.29%	-6.0%	0.0%
1 Year	278.62%	2.7%	0.0%
3 Years	33.58%	0.6%	-19.7%

Chromadex Key Statistics

in dollars & INR

Previous Close	$5.41
Open	$5.31
Today's High	$5.55
Today's Low	$5.26
Market Capitalization	$419.3M
Today's Volume	$1.1M
52 Week High	$7.9738
52 Week Low	$1.36
Revenue TTM	$91.7M
EBITDA	$1.3M
Earnings Per Share (EPS)	$0.02
PE Ratio	274.5
Profit Margin	1.62%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	4.82%

How to invest in Chromadex from India?

It is very easy for Indian residents to invest directly in Chromadex from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Chromadex stock in both Indian Rupees (INR) and US Dollars (USD). Search for Chromadex or CDXC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Chromadex or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Chromadex shares which would translate to 0.155 fractional shares of Chromadex as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Chromadex, in just a few clicks!

Returns in Chromadex for Indian investors in Rupees

Investment Value

₹1,00,000

Chromadex investment value today

Current value as on today

₹3,80,817

Returns

₹2,80,817

(+280.82%)

Returns from Chromadex Stock

₹2,78,621 (+278.62%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Chromadex

-80%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Chromadex on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -80% less investors are searching Chromadex in the last 30 days versus the previous period.

Global Institutional Holdings in Chromadex

Vanguard Group Inc
4.49%
BlackRock Inc
4.08%
Tieton Capital Management, LLC
3.87%
ICONIQ Capital, LLC
1.70%
Geode Capital Management, LLC
1.51%
State Street Corp
0.81%

Analyst Recommendation on Chromadex

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Chromadex(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Chromadex

What analysts predicted

Upside of 44.99%

Current:

$5.49

Target:

$7.96

Insights on Chromadex

Price Movement
In the last 1 month, CDXC stock has moved down by -28.0%
Increasing Revenue
Revenue is up for the last 5 quarters, 19.49M → 34.92M (in $), with an average increase of 12.5% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -492.0K → 1.87M (in $), with an average increase of 1640.4% per quarter

Chromadex Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$31.6M	↑ 48.84%
Net Income	$-33.3M	↑ 192.82%
Net Profit Margin	-105.57%	↓ 51.91%

	FY19	Y/Y Change
Revenue	$46.3M	↑ 46.69%
Net Income	$-31.5M	↓ 5.54%
Net Profit Margin	-67.99%	↑ 37.58%

	FY20	Y/Y Change
Revenue	$59.3M	↑ 28.01%
Net Income	$-18.5M	↓ 41.27%
Net Profit Margin	-31.19%	↑ 36.8%

	FY21	Y/Y Change
Revenue	$67.4M	↑ 13.82%
Net Income	$-25.6M	↑ 38.27%
Net Profit Margin	-37.89%	↓ 6.7%

	FY22	Y/Y Change
Revenue	$72.1M	↑ 6.82%
Net Income	$-14.4M	↓ 43.46%
Net Profit Margin	-20.05%	↑ 17.84%

	FY23	Y/Y Change
Revenue	$83.6M	↑ 15.99%
Net Income	$-4.9M	↓ 65.82%
Net Profit Margin	-5.91%	↑ 14.14%

	Q2 FY23	Q/Q Change
Revenue	$20.3M	↓ 9.9%
Net Income	$-2.2M	↑ 64.74%
Net Profit Margin	-10.78%	↓ 4.88%

	Q3 FY23	Q/Q Change
Revenue	$19.5M	↓ 4.07%
Net Income	$-959.0K	↓ 56.23%
Net Profit Margin	-4.92%	↑ 5.86%

	Q4 FY23	Q/Q Change
Revenue	$21.2M	↑ 8.73%
Net Income	$114.0K	↓ 111.89%
Net Profit Margin	0.54%	↑ 5.46%

	Q1 FY24	Q/Q Change
Revenue	$22.2M	↑ 4.52%
Net Income	$-492.0K	↓ 531.58%
Net Profit Margin	-2.22%	↓ 2.76%

	Q2 FY24	Q/Q Change
Revenue	$22.7M	↑ 2.65%
Net Income	$-15.0K	↓ 96.95%
Net Profit Margin	-0.07%	↑ 2.15%

	Q3 FY24	Q/Q Change
Revenue	$34.9M	↑ 53.57%
Net Income	$1.9M	↓ 12620.0%
Net Profit Margin	5.38%	↑ 5.45%

	FY18	Y/Y Change
Profit	$16.1M	↑ 53.24%

	FY19	Y/Y Change
Profit	$25.8M	↑ 60.5%

	FY20	Y/Y Change
Profit	$35.3M	↑ 36.89%

	FY21	Y/Y Change
Profit	$41.5M	↑ 17.62%

	FY22	Y/Y Change
Profit	$42.8M	↑ 3.15%

	FY23	Y/Y Change
Profit	$50.8M	↑ 18.65%

	Q2 FY23	Q/Q Change
Profit	$12.4M	↓ 8.6%

	Q3 FY23	Q/Q Change
Profit	$12.0M	↓ 3.13%

	Q4 FY23	Q/Q Change
Profit	$12.9M	↑ 8.09%

	Q1 FY24	Q/Q Change
Profit	$13.5M	↑ 4.01%

	Q2 FY24	Q/Q Change
Profit	$13.7M	↑ 1.76%

	Q3 FY24	Q/Q Change
Profit	$16.2M	↑ 18.6%

	FY18	Y/Y Change
Operating Cash Flow	$-20.9M	↑ 113.26%
Investing Cash Flow	$-1.8M	↓ 138.57%
Financing Cash Flow	$-90.0K	↓ 100.18%

	FY19	Y/Y Change
Operating Cash Flow	$-20.4M	↓ 2.24%
Investing Cash Flow	$-249.0K	↓ 85.97%
Financing Cash Flow	$16.9M	↓ 18860.0%

	FY20	Y/Y Change
Operating Cash Flow	$-10.6M	↓ 48.14%
Investing Cash Flow	$-165.0K	↓ 33.73%
Financing Cash Flow	$8.7M	↓ 48.77%

	FY21	Y/Y Change
Operating Cash Flow	$-24.2M	↑ 127.95%
Investing Cash Flow	$-409.0K	↑ 147.88%
Financing Cash Flow	$36.1M	↑ 317.27%

	FY22	Y/Y Change
Operating Cash Flow	$-15.1M	↓ 37.52%
Investing Cash Flow	$-334.0K	↓ 18.34%
Financing Cash Flow	$7.7M	↓ 78.79%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$3.3M	↑ 17.48%
Investing Cash Flow	$-5.0K	↓ 94.51%
Financing Cash Flow	$-10.0K	↑ 900.0%

Chromadex Technicals Summary

Sell

Neutral

Buy

Chromadex is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Chromadex Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Chromadex Corp	-28.05%	115.29%	278.62%	33.58%	-34.49%
Kraft Heinz Company, The	-1.83%	-8.1%	-16.06%	-13.07%	-4.39%
Mccormick & Company, Incorporated	1.17%	13.96%	16.19%	-15.56%	-5.7%
Hormel Foods Corporation	3.87%	2.33%	-0.25%	-33.58%	-30.22%
General Mills, Inc.	-0.8%	-6.55%	-1.4%	-3.18%	20.66%
Kellanova	-0.64%	38.17%	47.76%	28.23%	17.04%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Chromadex Corp	274.5	274.5	0.0	0.04	0.05	0.01	NA	0.45
Kraft Heinz Company, The	27.12	27.12	0.81	3.01	0.03	0.04	0.05	39.97
Mccormick & Company, Incorporated	26.61	26.61	2.62	2.91	0.15	0.05	0.02	20.2
Hormel Foods Corporation	21.55	21.55	3.07	1.58	0.1	0.05	0.04	14.35
General Mills, Inc.	13.92	13.92	3.26	4.5	0.24	0.07	0.04	16.81
Kellanova	26.87	26.87	1.63	3.75	0.26	0.06	0.03	10.59

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Chromadex Corp	Buy	$419.3M	-34.49%	274.5	1.62%
Kraft Heinz Company, The	Buy	$36.4B	-4.39%	27.12	5.24%
Mccormick & Company, Incorporated	Hold	$21.0B	-5.7%	26.61	11.87%
Hormel Foods Corporation	Hold	$17.4B	-30.22%	21.55	6.52%
General Mills, Inc.	Hold	$35.3B	20.66%	13.92	12.14%
Kellanova	Hold	$27.7B	17.04%	26.87	7.85%

About Chromadex

chromadex corp. is an integrated, global nutraceutical company devoted to improving the way people age. chromadex scientists partner with leading universities and research institutions worldwide to uncover the full potential of nad and identify and develop novel, science-based ingredients including pteropure® pterostilbene; purenergy®, a caffeine-pteropure® co-crystal; anthorigin™, anthocyanins and niagen® nicotinamide riboside - sold directly to consumers as the supplement, tru niagen®. tru niagen® is helping the world age better®. for more, visit www.chromadex.com like us on facebook here: https://www.facebook.com/chromadex or follow us on twitter @chromadex chromadex® is publicly-traded company (nasdaq:cdxc).

Organization	Chromadex
Employees	106
CEO	Mr. Frank Louis Jaksch Jr.
Industry	Process Industries

Management People of Chromadex

Name	Title
Mr. Frank Louis Jaksch Jr.	Co-Founder & Chairman
Mr. Robert N. Fried	CEO & Director
Mr. Ozan Pamir C.F.A.	CFO & Principal Accounting Officer
Dr. Andrew Shao Ph.D.	Senior Vice President of Global Regulatory & Scientific Affairs
Mr. Carlos Lopez	Senior VP & General Counsel
Alex Worsham	Vice President of Global Marketing & Communications
Ms. Michiko Kelley	Chief Marketing Officer
Ms. Chu Yan	Managing Director of Asia Pacific
Kendall Knysch	Head of Media Relations & Partnerships
Mr. James Lee	Controller

Important FAQs about investing in Chromadex from India :

What is Chromadex share price today?

Chromadex share price today stands at $5.49, Open: $5.31 ; Previous Close: $5.41 ; High: $5.55 ; Low: $5.26 ; 52 Week High: $7.97 ; 52 Week Low: $1.36. The stock opens at $5.31, after a previous close of $5.41. The stock reached a daily high of $5.55 and a low of $5.26, with a 52-week high of $7.97 and a 52-week low of $1.36.

Can Indians buy Chromadex shares?

Yes, Indians can invest in the Chromadex (CDXC) from India.

With INDmoney, you can buy Chromadex at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Chromadex at zero transaction cost.

How can I buy Chromadex shares from India?

It is very easy to buy Chromadex from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Chromadex be purchased?

Yes, you can buy fractional shares of Chromadex with INDmoney app.

What are the documents required to start investing in Chromadex stocks?

To start investing in Chromadex, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.